December 2017 FDA Recall Spiriva by Boehringer Ingelheim Pharmaceuticals, Inc.
D-0242-2018 - Failed Stability Specifications

This Class II drug recall was voluntarily initiated by Boehringer Ingelheim Pharmaceuticals, Inc. on December 14, 2017 for the product Spiriva. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0242-2018

Reason for Recall
Failed Stability Specifications
Initiated
12-14-2017
Reported
02-07-2018
Quantity
45,008 units/90 capsules each unit

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributed nationwide
SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) per box, Rx Only, Made in Germany, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0075-47

Batch or Lot Expiration Information

Lot# 606478; Exp. 03/18